Close Menu
Warsaw.Today
    What's Hot

    Vulcan failure caused by inadequate fuel supply to engines, ULA says

    November 18, 2026

    EU proposes €45bn Ukraine loan as Trump, Xi and Putin meet

    November 18, 2026

    Atmos is adding huge airfare rewards and new travel perks to its business card

    November 18, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Vulcan failure caused by inadequate fuel supply to engines, ULA says
    • EU proposes €45bn Ukraine loan as Trump, Xi and Putin meet
    • Atmos is adding huge airfare rewards and new travel perks to its business card
    • Pax Silica is the new face of US imperialism in the Philippines
    • Storms Bruna and Charles bring record rain and winds to Portugal and Madeira
    • Waymo suspends freeway driving after California construction zone complaint
    • Był twórcą “nurtu chłopskiego”. Jego bestsellerowa powieść zainspirowała znanego reżysera
    • Here’s the perfect 4-day Cayman Islands itinerary — and how to earn points along the way
    Facebook X (Twitter) Instagram
    Warsaw.TodayWarsaw.Today
    Demo
    • Home
    • News
    • World
    • Sports
    • Business
    • Culture
    • Politics
    • Travel
    • Technology
    Warsaw.Today
    Home»Technology»The FDA wants to pull its approval of a drug. It’s not so easy.
    Technology

    The FDA wants to pull its approval of a drug. It’s not so easy.

    Peter NovakBy Peter NovakOctober 31, 2026No Comments0 Views
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    The FDA wants to pull its approval of a drug. It’s not so easy.
    Share
    Facebook Twitter LinkedIn Pinterest Email

    In May 2021, the US Food and Drug Administration released a lengthy briefing document on an experimental medication for a rare autoimmune form of vasculitis that often damages the kidneys and lungs. The agency was on the fence about whether to approve the treatment, and it wanted an independent advisory committee to weigh in. Among the questions at hand: Was the drug meaningfully better than existing therapies?

    Participants in the study, which had been conducted by the California biotechnology company ChemoCentryx, did appear to have slightly higher rates of symptom remission after one year. But according to the FDA, it was hard to interpret the results because the study’s design had been less than optimal. Some advisory committee members expressed a similar view. The effect of the drug, said one, “is just not well verified by this study.”

    At the same time, many patients, and some physicians, saw in the data a potentially helpful medication, one that might lessen patients’ reliance on steroids, which are highly effective but often cause severe side effects.

    Source: arstechnica.com

    fda pull Science syndication wants
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Peter Novak
    • Website

    Related Posts

    Vulcan failure caused by inadequate fuel supply to engines, ULA says

    November 18, 2026

    Waymo suspends freeway driving after California construction zone complaint

    November 18, 2026

    Sony’s updated turntable is an easy entry into the world of vinyl

    November 18, 2026
    Leave A Reply Cancel Reply

    WARSAW WEATHER
    Economy News
    Technology

    Vulcan failure caused by inadequate fuel supply to engines, ULA says

    By Peter NovakNovember 18, 20260

    United Launch Alliance said Wednesday that the failure of its Vulcan rocket during a launch on Sunday was caused by inadequate fuel supply.

    EU proposes €45bn Ukraine loan as Trump, Xi and Putin meet

    November 18, 2026

    Atmos is adding huge airfare rewards and new travel perks to its business card

    November 18, 2026
    Top Trending
    News

    Pope Leo XIV to have surgery in ‘coming days’ to remove nodule in lung

    By Peter NovakOctober 11, 20260

    Pope Leo XIV announced on Sunday that he was scheduled to have surgery in the “coming days” to remove a nodule in his lung.

    World

    Mohamed Salah sets Turkish Super Lig record for Trabzonspor

    By Peter NovakOctober 11, 20260

    Mohamed Salah has set a new record in Turkiye’s top flight of club football, becoming the first player to have 10 goal contributions in his first seven games for Trabzonspor in the Turkish Super Lig.

    News

    Video. Zaporizhzhia airstrikes kill 17 as Russia intensifies attacks across Ukraine

    By Peter NovakOctober 11, 20260

    Guided aerial bombs struck residential buildings in Zaporizhzhia on Saturday, 10 October, killing at least 17 people, including three children, and injuring at least 18 others

    Subscribe to News

    Subscribe to receive the latest breaking news, local updates, and top stories from Warsaw delivered to your inbox.

    Warsaw.Today is your trusted source for breaking news, local updates, business, politics, technology, sports, culture, and events from Warsaw, Poland—all in one place.

    Facebook X (Twitter) Instagram Pinterest YouTube

    Vulcan failure caused by inadequate fuel supply to engines, ULA says

    November 18, 2026

    EU proposes €45bn Ukraine loan as Trump, Xi and Putin meet

    November 18, 2026

    Atmos is adding huge airfare rewards and new travel perks to its business card

    November 18, 2026

    Subscribe to Updates

    Subscribe to receive the latest breaking news, local updates, and top stories from Warsaw delivered to your inbox.

    © 2026 ThemeSphere. Designed by ThemeSphere.
    • About Us
    • Get In Touch
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.